Pfizer (PFE)

These healthcare leaders can make you money while you sleep.

Shares of BridgeBio Pharma are nearing a record high as the small biotech company takes on drug behemoths Pfizer and Alnylam.

Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.

Artificial intelligence, often spotlighted for its advancements in mainstream applications like conversational agents and autonomous vehicles, is quietly orchestrating a profound transformation across an array of specialized and niche domains. Far from the public eye, AI is demonstrating unparalleled versatility, solving complex, previously intractable problems and delivering significant impact in areas ranging from accelerated drug [...]

New York, NY – December 1, 2025 – The S&P 500 has begun December 2025 with a notable decline, signaling a profound shift in market sentiment as investors grapple with a confluence of challenging economic factors. This downturn, described by analysts as "rediscovering gravity," comes after a period of sustained upward

Moderna tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children.

Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".

If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to survive.

One drug developer could be on the cusp of AI-powered glory.

If you buy companies with in-demand products and hold for the long term, you can end up with long-term winners.

If you are thinking in decades and not days, this trio of dividend stocks could be the perfect starting point for your fledgling portfolio.

There are plenty of potential winners outside the world of AI.

Novo Nordisk's drug trial failure is the latest in a series of 2025 woes for the company.

Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.

From high-yield pharma plays to growth-oriented compounders, these eight stocks offer something for every dividend investor.

While Pfizer has lagged behind the broader Dow Jones Industrial Average, Wall Street remains optimistic about the stock.

Roivant (ROIV) Q2 2026 Earnings Call Transcript

These top dividend stocks could intrigue a wide range of investors.

JPMorgan said the implied net impact aligns with recent commentary from Novo Nordisk, Teva and AbbVie during earnings season.

Valneva's Phase 2 data show strong, lasting immunity for its Pfizer-partnered Lyme vaccine as the company consolidates operations in France.

Merck has outperformed the healthcare sector over the past three months. Moreover, Wall Street analysts are moderately optimistic about its prospects.

The weight loss drug market may approach almost $100 billion by the end of the decade.

The financial markets are currently navigating a turbulent sea of uncertainty, grappling with the profound implications of significantly delayed economic reports. As of November 25, 2025, the aftershocks of a recent 43-day U.S. government shutdown, which concluded on November 12th, have created an unprecedented "information vacuum." This scarcity of

This big pharma stock should be even more appealing to investors amid market turbulence.